Our new trial: The Etheral Study

Glasgow Memory Clinic is currently conducting several different clinical trials including Genes and Alzheimer’s and we are now pleased to offer the Etheral clinical trial.

The Etheral study is looking to see if a new drug is safe and well tolerated in people with mild-to-moderate Alzheimer’s disease. The study will look at two different dose levels and will test to see how the body handles the drug at these doses and which dose is the most effective.

 

What will happen if I take part?

Throughout the study, you will still be able to take your normal medication as usual. Participation is completely voluntary, and you are under no pressure to take part. If you decide to participate, you will be required to sign your consent. You may withdraw from the study at any time without having to give a reason by informing the study doctor. This study will not affect your medical care in any way. It is also worth noting that your care giver or family member will also need to provide their consent to participate.

 

How long will I be in this study?

The study will last approximately 52 weeks. During this time, you will be asked to attend to 17 visits, and will have a final follow-up visit after the end of the treatment, to the clinic. Your caregiver or close relative will be asked to accompany you to these visits and to respond to some questionnaires on your health status.

 

To qualify for this study, you must:
  • Be between 50 to 85 years
  • Have a caregiver or close relative
  • Be able to walk unaided or with a walker or walking stick
  • Take any of the following medications: Aricept, Donepezil, Rivastigimine, Exelon, Galantamine, Razdyne or Reminyl
  • Have a body mass index (BMI) of at least 18.4kg/m2?

 

If you qualify, you will be entitled to:
  • Investigational drug
  • Study-related care from a local study doctor
  • Reimbursement for travel expenses
What are the benefits of taking part?

For this study, there is no guarantee you will obtain additional direct benefit. However, you may help to improve treatment for people with Alzheimer’s in the future. Most of us have benefited from medical research for various things without necessarily realising it. People who take part in our research are invaluable in contributing towards the care, treatment and well-being of countless number of people, and without this, we wouldn’t be on track to finding a cure for Alzheimer’s.

 

Take our pre-screener survey and find our if you are suitable to take part here

Posted 19th February 2019

Leave a Reply